# Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture

> **NCT03251469** · PHASE2 · UNKNOWN · sponsor: **National and Kapodistrian University of Athens** · enrollment: 200 (estimated)

## Conditions studied

- Blood Loss, Surgical
- Hip Fractures
- Complication, Postoperative

## Interventions

- **DRUG:** Tranexamic Acid 15mg/kg , iv, Single Dose
- **DRUG:** Normal Saline, 100mg, iv, Singe dose

## Key facts

- **NCT ID:** NCT03251469
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03251469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03251469, "Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03251469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*